Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1146629-76-6

Post Buying Request

1146629-76-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl acetate [4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl

    Cas No: 1146629-76-6

  • USD $ 10.0-10.0 / Kilogram

  • 1 Kilogram

  • 1000 Kilogram/Week

  • WUHAN YING YUAN BEI TECHNOLOGY CO., LTD
  • Contact Supplier
  • [4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl pivalate

    Cas No: 1146629-76-6

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

1146629-76-6 Usage

General Description

The chemical "[4-[1-(1-ethoxyethyl)-1H-pyrazol-4-yl]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl" is a complex compound with a long molecular structure. It consists of a pyrrolopyrimidine core with a pyrazole group and an ethoxyethyl substituent. The compound is classified as a pyrrolo[2,3-d]pyrimidine derivative and contains a methyl group attached to the pyrrolopyrimidine core. The chemical structure suggests that it may possess biological activity and could potentially be used in pharmaceutical research and drug development. Further analysis and testing would be necessary to fully understand the properties and potential applications of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 1146629-76-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,4,6,6,2 and 9 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1146629-76:
(9*1)+(8*1)+(7*4)+(6*6)+(5*6)+(4*2)+(3*9)+(2*7)+(1*6)=166
166 % 10 = 6
So 1146629-76-6 is a valid CAS Registry Number.

1146629-76-6Upstream product

1146629-76-6Relevant articles and documents

BARICITINIB INTERMEDIATE, METHOD FOR FORMING BARICITINIB INTERMEDIATE, AND METHOD FOR PREPARING BARICITINIB OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

-

, (2019/07/15)

The present disclosure provides a Baricitinib intermediate, a method for preparing the Baricitinib intermediate, and a method for preparing Baricitinib or a pharmaceutically acceptable salt thereof using the Baricitinib intermediate. The method for preparing the Baricitinib intermediate involves the use of a divalent palladium catalyst or a nickel catalyst and provides the Baricitinib intermediate in high yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1146629-76-6